miR-122–5p targets GREM2 to protect against glucocorticoid-induced endothelial damage through the BMP signaling pathway

Glucocorticoid (GC)-induced osteonecrosis of the femoral head (ONFH) accounts for a big portion of non-traumatic ONFH; nevertheless, the pathogenesis has not yet been fully understood. GC-induced endothelial dysfunction might be a major contributor to ONFH progression. The Gene Expression Omnibus (GEO) dataset was analyzed to identify deregulated miRNAs in ONFH; among deregulated miRNAs, the physiological functions of miR-122–5p on ONFH and endothelial dysfunction remain unclear. In the present study, miR-122–5p showed to be under-expressed within GC-induced ONFH femoral head tissues and GC-stimulated bone microvascular endothelial cells (BMECs). In human umbilical vein endothelial cells (HUVECs) and BMECs, GC stimulation significantly repressed cell viability, promoted cell apoptosis and increased the mRNA expression of proinflammatory cytokines, such as TNF-α, IL-1β, and IFN-γ. After overexpressing miR-122–5p, GC-induced endothelial injuries were attenuated, as manifested by rescued cell viability, cell migration, and tube formation capacity. Regarding the BMP signaling, GC decreased the protein levels of BMP-2/6/7 and SMAD-1/5/8, whereas miR-122–5p overexpression significantly attenuated the inhibitory effects of GC on these proteins. Online tool and experimental analyses revealed the direct binding between miR-122–5p and GREM2, a specific antagonist of BMP-2. In contrast to miR-122–5p overexpression, GREM2 overexpression aggravated GC-induced endothelial injury; GREM2 silencing partially eliminated the effects of miR-122–5p inhibition on GC-stimulated HUVECs and BMECs. Finally, GREM2 silencing reversed the suppressive effects of GC on BMP-2/6/7 and SMAD-1/5/8, and attenuated the effects of miR-122–5p inhibition on these proteins upon GC stimulation. Conclusively, the present study demonstrates a miR-122–5p/GREM2 axis modulating the GC-induced endothelial damage via the BMP/SMAD signaling. Considering the critical role of endothelial function in ONFH pathogenesis, the in vivo role and clinical application of the miR-122–5p/GREM2 axis is worthy of further investigation. •GC-induced injuries in both HUVECs and BMECs.•miR-122-5p improves GC-induced endothelial cell injuries and dysfunction.•miR-122-5p targets GREM2 and negatively regulates GREM2 expression.•miR-122-5p/GREM2 axis modulates the GC-induced endothelial damage via BMP/SMAD signaling.